Quora Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.30 M
- Revenue Growth 53.00%
- Profit Growth 1400.80%
- Ebitda 43.13%
- Net Worth 15.59%
- Total Assets 20.63%
About Quora Pharmaceuticals
Quora Pharmaceuticals Private Limited (QPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 September 2015 (Nine years and five months 15 days old ). Its registered office is in Thane, Maharashtra, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Anupam Singh and Hemavati Singh serve as directors at the Company.
Company Details
- Location
Thane, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51101MH2015PTC268183
- Company No.
268183
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Quora Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Singh  | Director | 07-Sep-2015 | Current |
| Hemavati Singh | Director | 07-Sep-2015 | Current |
Financial Performance of Quora Pharmaceuticals.
Quora Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 53% increase. The company also saw a substantial improvement in profitability, with a 1400.8% increase in profit. The company's net worth Soared by an impressive increase of 15.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Quora Pharmaceuticals?
In 2019, Quora Pharmaceuticals had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹1.30 M
Charges Breakdown by Lending Institutions
- Others : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Feb 2017 | Others | ₹1.30 M | Satisfied |
How Many Employees Work at Quora Pharmaceuticals?
Quora Pharmaceuticals has a workforce of 31 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Quora Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Quora Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.